SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-18-006233
Filing Date
2018-05-17
Accepted
2018-05-17 07:45:19
Documents
12
Period of Report
2018-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp90977_6k.htm 6-K 13061
2 EXHIBIT 99.1 dp90977_ex9901.htm EX-99.1 158307
3 EXHIBIT 99.2 dp90977_ex9902.htm EX-99.2 79900
4 EXHIBIT 99.3 dp90977_ex9903.htm EX-99.3 132933
5 GRAPHIC image_014.jpg GRAPHIC 3142
6 GRAPHIC image_015.jpg GRAPHIC 3142
7 GRAPHIC image_016.jpg GRAPHIC 3142
8 GRAPHIC image_017.jpg GRAPHIC 3142
9 GRAPHIC image_018.jpg GRAPHIC 3142
10 GRAPHIC image_019.jpg GRAPHIC 3142
11 GRAPHIC image_020.jpg GRAPHIC 3142
12 GRAPHIC image_021.jpg GRAPHIC 3142
  Complete submission text file 0000950103-18-006233.txt   420995
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 18841725
SIC: 2834 Pharmaceutical Preparations